When the U.S. Food and Drug Administration cleared for the first time a surgical device that can be assembled and disassembled inside a patient’s body, not a lot of people noticed. That’s probably because the manufacturer, a Cincinnati-based surgical products division of Johnson & Johnson called Ethicon Endo-Surgery, hasn’t yet launched the product — and […]
Surgical products company Ethicon Endo-Surgery, a division of Johnson & Johnson (NYSE:JNJ), is entering the medical device reprocessing and remanufacturing business with a planned acquisition of SterilMed. The price of the deal isn’t being disclosed, according to a statement from Cincinnati-based Ethicon. With the cost of healthcare in the U.S. continuing to skyrocket, medical device […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Food and Drug Administration has reconsidered its denial of Ethicon Endo-Surgery Inc.'s application to begin selling a computer-assisted sedation system.
Surgical device company Ethicon Endo-Surgery Inc. has appealed the federal government's denial of its application to begin selling a sedation system for colonoscopy and upper gastrointestinal procedures.
Devicor Medical Products Group LLC, the medical device holding company that bought the breast-care business of Johnson & Johnson‘s Ethicon Endo-Surgery two weeks ago, has raised $151.5 million. Devicor Medical in Pleasant Prairie, Wisconsin raised the money from seven investors, beginning on July 9, according to a Securities and Exchange Commission (SEC) filing. Nearly $3.4 […]
Devicor Medical Products Inc., the Pleasant Valley, Wisconsin, fledgling holding company backed by Chicago private equity firm GTCR Golder Rauner LLC, has made its first acquisition: the breast care business of Johnson & Johnson’s Ethicon Endo-Surgery unit near Cincinnati, Ohio. Financial terms of the deal were not disclosed. But nearly 300 Ethicon Endo-Surgery employees who […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Device firm Ethicon Endo-Surgery Inc. has awarded a $13.5 million grant to the University of Cincinnati and others for collaborative obesity research. The three-year grant will be used to investigate how and why gastric bypass surgery works, according to a statement from Ethicon Endo-Surgery. Gastric bypass surgery often helps patients lose weight and can also […]
Johnson & Johnson (NYSE:JNJ) provided investors and analysts with a glimpse into its medical device operation, which it called the world’s largest. Over the past two years, according to the presentation, the division posted $1.8 billion in operational sales growth (excluding special items such as acquisitions or legal expenses). The segment’s total sales during the […]
Ethicon Endo-Surgery Inc. is entertaining an offer from a private equity-backed holding company for its breast care business, including the MammoTome biopsy system. The Johnson & Johnson (NYSE:JNJ) subsidiary has until June 15 to decide whether to accept the offer from Devicor Medical Products, a portfolio company of GTCR Golder Rauner LLC. Specific terms of […]
Ethicon Endo-Surgery Inc. and a subsidiary of Hologic Inc. have settled their patent infringement disagreements with a $12.5 million payment to Ethicon and the promise to share royalties from selling each other's breast cancer biopsy devices.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A federal judge in Georgia ordered Johnson & Johnson subsidiary Ethicon Endo-Surgery to produce documents subpoenaed in a product liability lawsuit over Mentor Corp.'s ObTape bladder sling.
The U.S. Department of Justice has sued Johnson & Johnson, accusing it of paying Omnicare Inc. in Covington, Ky., millions of dollars in kickbacks to buy and recommend J&J's drugs for patients in nursing homes.